Cookies

Like most websites The Medicine Maker uses cookies. In order to deliver a personalized, responsive service and to improve the site, we remember and store information about how you use it. Learn more.

Manufacture

Manufacture Advanced Medicine

Let’s Focus on Filtration

| Morven McAlister, Aernout Martens

Gene therapy manufacturers will need to focus on upstream filtration to minimize the risk of viral infection.

Manufacture Ingredients

The Crystal Maze

| David Pearson

How can manufacturers avoid frustrating and inadvertent changes to the solid forms of APIs?

Manufacture Quality & Compliance

Zero Defects

| Massimo Mainetti

Lives and livelihoods depend on accelerating large molecule drug production, so biopharma companies must minimize defects and contamination.

Manufacture Technology and Equipment

The Innovation Awards 2020

In December, The Medicine Maker will showcase the top technologies to have been released throughout 2020. Nominations are now open.

Manufacture Vaccines

Success at Speed: Digging into Accelerated Vaccine Development (Part 1)

| Amélie Boulais, Piergiuseppe Nestola

As the world grasps the severity of the ongoing pandemic, we must ask how we can accelerate vaccine development safely.

Manufacture Vaccines

Success at Speed Part 2: Regulatory Considerations

| Piergiuseppe Nestola, Amélie Boulais

It is well accepted that vaccine development needs to move faster, but how can companies balance compliance and speed?

Manufacture COVID-19

Pandemic Profiteering

| Maryam Mahdi

How are counterfeiters exploiting the COVID-19 pandemic to make a profit?

Manufacture Contract Development Services

A Greener Toolbox

| Martin Hayes

There are ample opportunities for pharma companies to transition to greener chemical processes. Martin Hayes from Johnson Matthey tells us more.

Manufacture Ingredients

Getting a Handle on High Potency

| Alyn McNaughton

We need to optimize and then accelerate HPAPI drug product development. Alyn McNaughton from Lonza tells us more.

Manufacture Advanced Medicine

Cell Therapy 2.0

| Pippa Gledhill

Advanced medicine companies are shifting their focus to off-the-shelf approaches, solid tumors, and combinations with immune checkpoint modulators.

Register to The Medicine Maker

Register to access our FREE online portfolio, request the magazine in print and manage your preferences.

You will benefit from:

  • Unlimited access to ALL articles
  • News, interviews & opinions from leading industry experts
  • Receive print (and PDF) copies of The Medicine Maker magazine

Register